Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Spillane

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Clinical Pathology|June 4, 2015
Enhanced regulation of cell cycle and suppression of osteoblast differentiation molecular signatures by prostate cancer stem-like holoclonesMichael F Gallagher, Yvonne Salley, Cathy D Spillane, et al.
Plos One|December 28, 2020
The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancerMark Bates, Cathy D Spillane, Michael F Gallagher, et al.
Oncotarget|October 17, 2015
Endosomal gene expression: a new indicator for prostate cancer patient prognosis?Ian R D Johnson, Emma J Parkinson-Lawrence, Helen Keegan, et al.
Journal of Ovarian Research|January 21, 2012
Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samplesMichael F Gallagher, Cynthia Cbb Heffron, Alexandros Laios, et al.
Scientific Reports|March 6, 2023
Ex vivo expansion of circulating tumour cells (CTCs)Bashir M Mohamed, Mark P Ward, Mark Bates, et al.
Heliyon|February 7, 2023
CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversityB Ffrench, E Kashdan, Y Huang, et al.
Pathology, Research and Practice|December 16, 2023
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancerMark Bates, Dorinda Mullen, Eimear Lee, et al.
Translational Oncology|September 30, 2021
The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenonCathy D Spillane, Niamh M Cooke, Mark P Ward, et al.
Plos One|July 1, 2014
The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancerCharles J d'Adhemar, Cathy D Spillane, Michael F Gallagher, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Clinical Pathology|June 4, 2015
Enhanced regulation of cell cycle and suppression of osteoblast differentiation molecular signatures by prostate cancer stem-like holoclonesMichael F Gallagher, Yvonne Salley, Cathy D Spillane, et al.
Plos One|December 28, 2020
The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancerMark Bates, Cathy D Spillane, Michael F Gallagher, et al.
Oncotarget|October 17, 2015
Endosomal gene expression: a new indicator for prostate cancer patient prognosis?Ian R D Johnson, Emma J Parkinson-Lawrence, Helen Keegan, et al.
Journal of Ovarian Research|January 21, 2012
Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samplesMichael F Gallagher, Cynthia Cbb Heffron, Alexandros Laios, et al.
Scientific Reports|March 6, 2023
Ex vivo expansion of circulating tumour cells (CTCs)Bashir M Mohamed, Mark P Ward, Mark Bates, et al.
Heliyon|February 7, 2023
CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversityB Ffrench, E Kashdan, Y Huang, et al.
Pathology, Research and Practice|December 16, 2023
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancerMark Bates, Dorinda Mullen, Eimear Lee, et al.
Translational Oncology|September 30, 2021
The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenonCathy D Spillane, Niamh M Cooke, Mark P Ward, et al.
Plos One|July 1, 2014
The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancerCharles J d'Adhemar, Cathy D Spillane, Michael F Gallagher, et al.
Pageof 2